PRELIMINARY AGENDA
Dates to be determined, (beginning 13:00)
(Open to independent academic and clinical members only)
- PNH guidelines (diagnosis and treatment assessment)
- Patient registry
- IPIG strategic priorities, 2020-2025
Dates to be determined (beginning 08:30)
(Open to all)
- Pathophysiology of PNH
- Current understanding of the pathophysiology of PNH
- Molecular and biologic aspects of the GPI-defect in PNH
- Mechanism of thrombosis
- Diagnosis and Investigation
- Diagnostic testing for PNH
- Investigation of PNH
- Definition of breakthrough
- Current Thoughts on the Complement System
- Recent developments in the terminal complement inhibition in PNH
- Proximal complement inhibition in PNH
- Discussion / Abstracts
- Recent data on complement inhibition in PNH (corporate presentations)
- Posters
- Member reception
Dates to be determined (beginning 08:30; ending 13:00)
(Open to all)
- Aplastic Anaemia
- Recent insights into the pathophysiology of AA
- Current non-transplant management of AA
- Transplant/cellular therapies in AA and PNH
- Definitions, guidelines, PNH across the globe
- Abstracts / Discussion
Faculty
- Bing Han, MD
Department of Haematology
Peking Union Medical College Hospital
Beijing, China
- Peter Hillmen, MB, ChB,PhD
St. James’s Institute of Oncology
Leeds Teaching Hospitals
NHS Trust
Leeds, United Kingdom
- Taroh Kinoshita, PhD
Department of Immunoregulation
Research Institute for Microbial Diseases
Osaka University
Osaka, Japan
- Alexander Kulagin, MD, PhD
Pavlov First St. Petersburg State Medical University
St. Petersburg, Russia
- Austin Kulasekararaj, MBBS, MD
King’s College Hospital
NHS Foundation Trust
London, United Kingdom
- John D. Lambris, PhD
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, USA
- Saskia Langemeijer, MD
Radboud University Medical Center
Nijmegen, Netherlands
- Regis Peffault de Latour, MD, PhD
Research Institute for Microbial Diseases
Hôpital Saint-Louis
Paris, France
- Jong Wook Lee, MD
The Catholic University of Korea
Seoul St. Mary’s Hospital
Seoul, Korea
- Lucio Luzzatto, MD
Muhimbili University of Health and Applied Sciences
Dar es Salaam, Tanzania
- Judith Marsh, BSc, MB, ChB
King’s College Hospital
NHS Foundation Trust
London, United Kingdom
- Petra Muus, MD, PhD
Department of Haematology
King’s College Hospital
London, United Kingdom
- Shinji Nakao, MD, PhD
Cellular Transplantation Biology
Kanazawa University Graduate School of Medical Science
Kanazawa, Ishikawa, Japan
- Junichi Nishimura, MD, PhD
Osaka University Graduate School of Medicine
Osaka, Japan
- Charles J. Parker, MD
Division of Hematology and Bone Marrow Transplantation
University of Utah School of Medicine
Salt Lake City, Utah, USA
- Stephen John Richards, PhD
Leeds Teaching Hospitals
NHS Trust
Leeds, United Kingdom
- Antonio M. Risitano, MD, PhD
Federico II University
Naples, Italy
- Gérard Socié, MD, PhD
Hôpital Saint-Louis
Paris, France
- Jeff Szer, BMedSc MB BS
Peter MacCallum Cancer Centre
The Royal Melbourne Hospital
Victoria, Australia
- Ronald P. Taylor, PhD
Department of Biochemistry
University of Virginia
Charlottesville, Virginia, USA
- Russell E. Ware, MD, PhD
Cincinnati Children’s Hospital
Cincinnati, Ohio, USA
- Neal S. Young, MD
National Heart, Lung, and Blood Institute
National Institutes of Health
Washington, DC, USA
- Rodrigo T. Calado, MD, PhD
Department of Internal Medicine
Ribeirão Preto School of Medicine University of São Paulo
Ribeirão Preto, Brazil
- Phillip Scheinberg, MD
Hospital São José
Beneficencia Portuguesa de São Paulo
São Paulo, Brazil
The registration fee for this event is £50 (GBP)
There are a number available for trainees and young investigators. More information will be available soon.
To register your interest in receiving updates about this workshop, please contact derry@collaborativeconferences.co.uk
For corporate sponsorship enquiries, please contact Heather Hollowell: info@pnhinterestgroup.org
More information in our Preliminary workshop brochure